TY -
GEN
AU - Nauseef, Jones T.
AU - Singh, Sharon
AU - Tan, Angela
AU - Patel, Amie
AU - Robinson, Brian D.
AU - Khani, Francesca
AU - Drake, Charles G.
AU - Lim, Emerson A.
AU - Stein, Mark N.
AU - Heath, Elisabeth I.
AU - Beltran, Himisha
AU - Molina, Ana M.
AU - Faltas, Bishoy Morris
AU - Ballman, Karla V.
AU - Sternberg, Cora N.
AU - Tagawa, Scott T.
AU - Nanus, David M.
TI -
Open label phase II trial of cabozantinib (cabo) in patients with metastatic castrate resistant prostate cancer (mCRPC) and known amplifications or activating mutations in gene targets who have received prior anti-androgen therapy.
PB - American Society of Clinical Oncology (ASCO)
SN - 0732-183X
SN - 1527-7755
KW - Cancer Research
KW - Oncology
PY - 2021
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -